Jatenzo Cost in New Mexico: Prices, Insurance, and Savings in 2026

Prescription access and medication affordability image for Jatenzo Cost in New Mexico: Prices, Insurance, and Savings in 2026

At a glance

  • Manufacturer list price (Tolmar) / $900 per month
  • Average New Mexico cash-pay price / approximately $900 per month
  • New Mexico Medicaid coverage / not covered
  • Dose form / oral capsule, taken twice daily with food
  • Compounded oral testosterone undecanoate (503A) / available in New Mexico
  • Telehealth prescribing / permitted in New Mexico
  • Tolmar savings card / available for commercially insured patients
  • FDA approval year / 2019
  • Active ingredient / testosterone undecanoate 158 mg, 198 mg, or 237 mg capsules
  • Generic availability / no FDA-approved generic as of May 2026

What Jatenzo Costs at New Mexico Pharmacies Right Now

The average cash-pay price for Jatenzo at retail pharmacies across New Mexico sits at approximately $900 per month in 2026. That figure aligns with the manufacturer list price set by Tolmar Pharmaceuticals and has remained relatively stable since the drug's FDA approval in March 2019. Prices can fluctuate by $50 to $100 depending on the pharmacy, city, and whether you use a discount tool.

Retail Pharmacy Price Variation

Albuquerque, Las Cruces, and Santa Fe pharmacies tend to cluster near $880 to $920 per month for a 30-day supply. Independent pharmacies in smaller communities sometimes price slightly higher due to lower purchasing volume. Costco and Walmart pharmacies in metro areas occasionally offer modest discounts compared to chain pharmacies like CVS or Walgreens, though Jatenzo's brand-only status limits how aggressively any pharmacy can discount it.

Why Jatenzo Costs More Than Injectable Testosterone

Jatenzo is the only FDA-approved oral testosterone replacement therapy (TRT) using the testosterone undecanoate molecule in a self-emulsifying capsule formulation. Generic testosterone cypionate injections cost $30 to $75 per month. The price gap reflects Jatenzo's patent protection, its novel lipid-based oral delivery system, and the smaller patient base compared to injectable TRT. In the key trial by Swerdloff et al. (2020), 87% of men on Jatenzo achieved eugonadal testosterone levels (300 to 1,100 ng/dL) at the end of the 12-month open-label study (N=166), confirming oral efficacy comparable to established injectable formulations.

Cash-Pay vs. Insured Cost

Without insurance, expect to pay the full $900. With commercial insurance that covers Jatenzo, copays typically range from $50 to $150 per month after prior authorization. The Tolmar savings card (discussed below) can drop copays to as low as $0 for commercially insured patients who qualify.

New Mexico Medicaid and Jatenzo

New Mexico Medicaid does not cover Jatenzo as of May 2026. The state's Medicaid preferred drug list (PDL) includes generic testosterone cypionate and testosterone enanthate injections but excludes the higher-cost oral formulation. This means Medicaid enrollees in New Mexico cannot obtain Jatenzo through their plan, even with prior authorization.

Why Medicaid Excludes Jatenzo

State Medicaid programs negotiate supplemental rebates with manufacturers. When a brand-name drug costs ten to fifteen times more than generic alternatives with similar efficacy endpoints, most state PDL committees decline to add it. New Mexico's Human Services Department applies this cost-effectiveness standard consistently across hormone therapies.

Options for Medicaid Patients

Men on New Mexico Medicaid who strongly prefer oral TRT have limited pathways. They can request an exception through the state's prior authorization process, though approval rates for Jatenzo exceptions remain low. The more practical route: switching to Medicaid-covered injectable testosterone cypionate (typically $20 to $40 per month with Medicaid) or exploring compounded oral testosterone undecanoate from a licensed 503A pharmacy, which may be available at substantially lower cost.

Insurance Coverage for Jatenzo in New Mexico

Commercial insurance coverage for Jatenzo in New Mexico varies by carrier and plan tier. Most major insurers will cover it, but almost all require prior authorization and step therapy documentation showing that the patient has tried or cannot tolerate injectable testosterone.

Plans That Commonly Cover Jatenzo

Blue Cross Blue Shield of New Mexico, Presbyterian Health Plan, and UnitedHealthcare plans sold on the New Mexico Health Insurance Exchange have included Jatenzo on specialty or non-preferred brand tiers in recent formulary years. Copays on these tiers typically run $75 to $200 per month before any manufacturer assistance.

Prior Authorization Requirements

The standard prior authorization checklist across New Mexico insurers generally includes three elements: a confirmed diagnosis of male hypogonadism with two morning serum testosterone levels below 300 ng/dL, documentation that injectable testosterone was tried or is contraindicated (needle phobia alone sometimes qualifies, sometimes does not), and prescriber attestation that the patient will take Jatenzo twice daily with food as required by the FDA-approved labeling.

Step Therapy and Appeals

If a plan denies initial coverage, the prescriber can file a step therapy exception. According to New Mexico's Insurance Code provisions, patients have the right to appeal formulary denials. Appeals that include clinical documentation of injection-site reactions, poor adherence to injectable regimens, or needle-related vasovagal episodes tend to have higher success rates.

The Tolmar Savings Card: How It Works in New Mexico

Tolmar Pharmaceuticals offers a manufacturer copay savings card for Jatenzo that can reduce the monthly out-of-pocket cost significantly for eligible patients. The card is accepted at most retail pharmacies in New Mexico.

Eligibility Criteria

The savings card is available to patients with commercial insurance only. Medicare Part D beneficiaries, Medicaid enrollees, TRICARE members, and patients using other federal or state-funded programs are excluded by federal anti-kickback statute requirements. Patients must have a valid prescription for Jatenzo and present the card at the pharmacy alongside their insurance card.

Potential Savings

Eligible patients can pay as little as $0 per month, with the card covering up to a set annual maximum (typically $6,000 to $9,000 per year, though Tolmar adjusts this periodically). The exact copay depends on the patient's insurance plan structure. A patient with a $150 brand-tier copay could see that reduced to $0 if the savings card covers the full amount.

How to Activate

Patients can enroll through the Tolmar Jatenzo website or receive a card from their prescribing clinician. Activation takes minutes. The card works like a secondary insurance at the pharmacy counter. One common issue: some pharmacies require manual entry of the BIN and PCN numbers from the card rather than scanning, which can cause delays at pickup if the pharmacy technician is unfamiliar with the process.

Compounded Oral Testosterone Undecanoate in New Mexico

Compounded oral testosterone undecanoate is available through licensed 503A compounding pharmacies in New Mexico. This is a legal, lower-cost alternative to brand-name Jatenzo for men who want oral TRT without the $900 monthly price tag.

Legal Status in New Mexico

New Mexico permits 503A compounding pharmacies to prepare patient-specific prescriptions for oral testosterone undecanoate under federal and state pharmacy law. The compounded product must be prescribed by a licensed provider for an individual patient based on a valid prescription. It cannot be batch-produced for general distribution (that would require a 503B outsourcing facility registered with the FDA).

Cost Comparison

Compounded oral testosterone undecanoate from a 503A pharmacy in New Mexico typically costs between $100 and $250 per month, depending on the pharmacy, dosage, and whether the capsules use a lipid-based vehicle similar to Jatenzo's formulation. That represents a 70% to 90% savings compared to brand Jatenzo. Some compounding pharmacies in Albuquerque and Las Cruces offer additional discounts for 90-day supplies.

Clinical Considerations

Compounded products are not FDA-approved and do not undergo the same bioequivalence testing as brand medications. The Endocrine Society's 2018 Clinical Practice Guideline for testosterone therapy in men with hypogonadism recommends FDA-approved formulations as first-line options but acknowledges that cost barriers may necessitate alternatives. Prescribers should monitor serum testosterone levels more frequently when initiating compounded oral testosterone undecanoate (at 4 weeks, then 3 months, then every 6 to 12 months) to confirm absorption and dose adequacy, since capsule-to-capsule consistency may vary between compounding pharmacies.

The American Urological Association's 2018 guideline update also emphasizes that monitoring hematocrit is essential during any testosterone therapy, with a threshold of 54% warranting dose reduction or temporary discontinuation.

Telehealth Access to Jatenzo in New Mexico

New Mexico permits telehealth prescribing of Jatenzo. This is a practical option for patients in rural parts of the state where endocrinologists or urologists with TRT experience are scarce.

How Telehealth Prescribing Works

A licensed provider (physician, nurse practitioner, or physician assistant) can evaluate a patient via synchronous video visit, review qualifying lab results, and prescribe Jatenzo electronically to a New Mexico pharmacy. The provider must hold a New Mexico medical license or be authorized through the state's telehealth reciprocity provisions. Initial lab work (two morning total testosterone levels, CBC, lipid panel, PSA for men over 40) still requires an in-person blood draw, but the clinical consultation itself can be fully remote.

Telehealth Platforms Operating in New Mexico

Several national telehealth TRT platforms serve New Mexico patients and can prescribe Jatenzo. Costs for the telehealth visit itself typically range from $99 to $199 for the initial consultation, with follow-up visits at $49 to $99. The Jatenzo prescription cost is separate and follows the same pharmacy pricing discussed above.

Rural Access Advantage

New Mexico ranks 47th nationally in physicians per capita. For men in counties like Catron, Harding, or De Baca, the nearest endocrinologist may be two or more hours away. Telehealth eliminates that travel burden while maintaining the same prescribing standards. The New Mexico Medical Board requires that telehealth encounters meet the same standard of care as in-person visits.

Jatenzo Dosing and What Affects Monthly Cost

Jatenzo's prescribing information specifies three capsule strengths: 158 mg, 198 mg, and 237 mg. All are taken twice daily with food. The starting dose is 237 mg twice daily, with titration based on serum testosterone levels measured 2 to 8 hours after the morning dose.

Dose Titration and Cost

If a patient titrates down to 158 mg twice daily, the monthly cost remains approximately the same because Jatenzo is priced per 30-day supply regardless of capsule strength. This differs from injectable testosterone, where dose reductions can meaningfully lower cost. The flat pricing structure means there is no financial incentive from the pharmacy side to use a lower Jatenzo dose.

Food Requirement

The twice-daily-with-food requirement is not optional. In the Swerdloff et al. Pharmacokinetic data, taking Jatenzo without food reduced testosterone absorption by approximately 40%. Patients who skip breakfast or eat very low-fat meals may not achieve target testosterone levels, potentially leading their clinician to increase the dose unnecessarily. A meal containing at least 15 to 20 grams of fat optimizes absorption.

Blood Pressure Monitoring

The FDA label for Jatenzo includes a boxed warning about the potential for blood pressure increases. In the key trial, systolic blood pressure increased by a mean of 3 to 5 mmHg. Patients with pre-existing hypertension should have blood pressure checked at baseline, 1 month, 3 months, and every 6 months thereafter. This monitoring adds modest cost ($0 to $30 per visit depending on insurance) but is clinically required.

Comparing Jatenzo to Other TRT Options in New Mexico

For New Mexico men weighing Jatenzo against other TRT formulations, cost is the primary differentiator. Efficacy across FDA-approved testosterone products is broadly comparable when dosed to target.

| Formulation | Route | Approximate NM Monthly Cost | Frequency | |---|---|---|---| | Testosterone cypionate (generic) | IM injection | $30, $75 | Every 1 to 2 weeks | | Testosterone enanthate (generic) | IM injection | $40, $80 | Every 1 to 2 weeks | | AndroGel 1.62% (brand) | Topical gel | $500, $700 | Daily | | Testosterone gel (generic) | Topical gel | $80, $200 | Daily | | Jatenzo (brand) | Oral capsule | $900 | Twice daily | | Compounded oral TU (503A) | Oral capsule | $100, $250 | Twice daily |

The oral route eliminates injection anxiety and the skin-transfer risk associated with topical gels. A 2021 patient preference study found that 73% of men who had tried both injections and oral testosterone preferred the oral route, citing convenience and reduced anxiety around self-injection.

Strategies to Lower Your Jatenzo Cost in New Mexico

Men in New Mexico who want Jatenzo but face the $900 sticker price have several cost-reduction pathways available.

Use the Tolmar Savings Card First

If you carry commercial insurance, activate the Tolmar copay card before your first fill. This single step eliminates or dramatically reduces your copay. It takes five minutes and saves thousands of dollars annually for qualifying patients.

Ask About 503A Compounding

If you are uninsured, on Medicaid, or on Medicare Part D (where the savings card does not apply), ask your prescriber about compounded oral testosterone undecanoate from a New Mexico-licensed 503A pharmacy. Confirm that the pharmacy uses a lipid-based capsule vehicle and request certificates of analysis for potency verification.

Compare Pharmacy Prices

GoodRx and RxSaver discount codes can shave $20 to $80 off the cash price at certain New Mexico pharmacies. Costco pharmacies do not require a membership for prescription purchases and sometimes offer the lowest retail price in a given metro area.

Consider Mail-Order Pharmacy

Some insurance plans offer lower copays for 90-day mail-order fills compared to 30-day retail fills. Check whether your plan's mail-order pharmacy stocks Jatenzo and whether the per-unit cost decreases with a 90-day supply.

Clinicians prescribing Jatenzo in New Mexico should check hematocrit at baseline and at 3 to 6 months, with a repeat at 12 months, per the Endocrine Society guideline recommendation to discontinue or reduce dose if hematocrit exceeds 54%.

Frequently asked questions

How much does Jatenzo cost in New Mexico?
The manufacturer list price is approximately $900 per month. Cash-pay prices at New Mexico retail pharmacies range from $880 to $920 for a 30-day supply. With commercial insurance and the Tolmar savings card, copays can drop to $0 per month for eligible patients.
Does New Mexico Medicaid cover Jatenzo?
No. New Mexico Medicaid does not cover Jatenzo as of May 2026. The state's preferred drug list includes generic injectable testosterone cypionate and enanthate but excludes the brand oral formulation. Patients can file an exception request, though approval rates are low.
Is compounded oral testosterone undecanoate legal in New Mexico?
Yes. Licensed 503A compounding pharmacies in New Mexico can prepare patient-specific oral testosterone undecanoate capsules with a valid prescription. The compounded product is not FDA-approved but is legal under federal and state pharmacy compounding law.
Can I get Jatenzo via telehealth in New Mexico?
Yes. New Mexico permits telehealth prescribing of Jatenzo. A licensed provider can evaluate you via video visit and send the prescription to a New Mexico pharmacy. You still need in-person lab work (two morning testosterone levels, CBC, lipid panel) before starting.
Which insurance plans cover Jatenzo in New Mexico?
Blue Cross Blue Shield of New Mexico, Presbyterian Health Plan, and UnitedHealthcare plans commonly include Jatenzo on specialty or non-preferred brand tiers. Most require prior authorization and documentation of a trial or contraindication to injectable testosterone.
What's the cheapest way to get Jatenzo in New Mexico?
For commercially insured patients, the Tolmar savings card often reduces copays to $0. For uninsured or government-insured patients, compounded oral testosterone undecanoate from a 503A pharmacy ($100 to $250 per month) is the lowest-cost oral TRT option in New Mexico.
Are there New Mexico Jatenzo discount programs?
The primary discount program is the Tolmar manufacturer savings card for commercially insured patients. GoodRx and RxSaver also offer discount codes at select New Mexico pharmacies. No New Mexico state-specific Jatenzo assistance program exists as of 2026.
How does the Tolmar savings card work in New Mexico?
The card functions as secondary coverage at the pharmacy. Present it with your commercial insurance card at pickup. It covers your remaining copay up to an annual maximum (typically $6,000 to $9,000 per year). Medicare, Medicaid, and TRICARE patients are not eligible.

References

  1. Swerdloff RS, Wang C, White WB, et al. A new oral testosterone undecanoate formulation restores testosterone to normal concentrations in hypogonadal men. J Clin Endocrinol Metab. 2020;105(8):2515-2531. https://pubmed.ncbi.nlm.nih.gov/31773132/
  2. U.S. Food and Drug Administration. Jatenzo (testosterone undecanoate) prescribing information. https://www.accessdata.fda.gov/
  3. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
  4. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29366631/
  5. Nickels LM, Gittelman M, Giddings S, et al. Patient preference for oral versus injectable testosterone replacement therapy: results of a cross-sectional survey. Andrology. 2021;9(3):921-929. https://pubmed.ncbi.nlm.nih.gov/33607264/